Dolutegravir + Lamivudine 50 mg / 300 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 50 mg / 300 mg
Reference Brands: Dovato(EU & US)
Category: Anti Viral
Dolutegravir + Lamivudine is a two-drug HIV-1 treatment that combines an integrase inhibitor and an NRTI for effective viral suppression. Marketed as Dovato, it offers once-daily dosing, fewer side effects, and is FDA and EMA approved for treatment-naïve patients.
Product Description:
Dolutegravir + Lamivudine is a fixed-dose combination antiretroviral medication used to treat HIV-1 infection in adults and adolescents. This two-drug regimen combines Dolutegravir, an integrase strand transfer inhibitor (INSTI), and Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI), to effectively suppress viral replication. Marketed under the brand name Dovato, it offers once-daily oral dosing with a simplified regimen, reducing pill burden. Approved by the US FDA and EMA, this dual therapy is recommended for treatment-naïve patients with no resistance to either drug. Dolutegravir + Lamivudine is known for its high efficacy, tolerability, and minimal side effects, supporting long-term HIV manageme
Dolutegravir + Lamivudine — third party manufacturing & bulk supply
Dolutegravir + Lamivudine 50 mg / 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dolutegravir + Lamivudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dolutegravir + Lamivudine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dolutegravir and lamivudine are used together as a complete two-drug regimen for the treatment of HIV-1 infection in adults and adolescents. This combination helps suppress viral replication, maintains viral load control, and reduces pill burden while offering an effective long-term treatment option.
It is made from Dolutegravir, an integrase strand transfer inhibitor, and Lamivudine, a nucleoside reverse transcriptase inhibitor. These two active substances work synergistically to block different stages of the HIV replication cycle.
The trade name for this combination is Dovato.
Dovato is manufactured by ViiV Healthcare.
The generic name is Dolutegravir + Lamivudine.
The brand name is Dovato.
It is manufactured in the UK and Europe by ViiV Healthcare, and licensed generic versions are produced in India by approved pharmaceutical manufacturers for global supply.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
